Neonatal Opioid Withdrawal Syndrome

被引：2

作者：

Easterlin, Molly Crimmins ^{[1
]}

Ramanathan, Rangasamy ^{[2
,3
,4
,5
,6
,7
]}

De Beritto, Theodore ^{[8
]}

机构：

[1] Univ Southern Calif, Div Neonatol, Dept Pediat, LAC USC Med Ctr,Keck Sch Med, Los Angeles, CA 90007 USA

[2] Univ Southern Calif, Div Neonatal Med, LAC USC Med Ctr, Los Angeles, CA 90007 USA

[3] Univ Southern Calif, PIH Good Samaritan Hosp, Los Angeles, CA 90007 USA

[4] Univ Southern Calif, Neonatal Perinatal Med Fellowship, Los Angeles, CA 90007 USA

[5] Univ Southern Calif, NICU, LAC USC Med Ctr, Los Angeles, CA 90007 USA

[6] Univ Southern Calif, Neonatal Hemodynam Program, LAC USC Med Ctr, Keck Sch Med, Los Angeles, CA 90007 USA

[7] Univ Southern Calif, Neonatal Resp Therapy Serv, LAC USC Med Ctr, Keck Sch Med, Los Angeles, CA 90007 USA

[8] Univ Calif Los Angeles, David Geffen Sch Med, Pediat, Div Neonatol,Dept Pediat,Mattel Childrens Hosp, Los Angeles, CA 90095 USA

来源：

PEDIATRIC ANNALS | 2022年 / 51卷 / 06期

关键词：

ABSTINENCE SYNDROME; UNITED-STATES; USE DISORDER; BUPRENORPHINE; ASSOCIATION; METHADONE; PROTOCOL;

D O I：

10.3928/19382359-20220407-05

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Opioid use, both prescribed and illicit, has grown exponentially in the United States since the late 1990s, and with it, opioid use during pregnancy and neonatal abstinence syndrome (NAS) have also increased. NAS is a withdrawal syndrome occurring in newborns that results from maternal opioid use during pregnancy and has variable onset, severity, and duration. Given the increasing incidence of NAS, this article seeks to review its definition, presentation, evaluation, and management to ensure adequate care of these infants and families.

引用

页码：E234 / E242

页数：9

共 50 条

[1] Neonatal Opioid Withdrawal Syndrome
Patrick, Stephen W.
Barfield, Wanda D.
Poindexter, Brenda B.
PEDIATRICS, 2020, 146 (05)
[2] Neonatal Opioid Withdrawal Syndrome
Sutter, Mary Beth
Leeman, Lawrence
Hsi, Andrew
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2014, 41 (02) : 317 - +
[3] Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
Tobacyk, Julia
Parks, Brian J.
Salazar, Paloma
Coward, Lori U.
Berquist, Michael D.
Gorman, Gregory S.
Brents, Lisa K.
DRUG AND ALCOHOL DEPENDENCE, 2023, 249
[4] Opioid Use Disorder and Neonatal Opioid Withdrawal Syndrome in Rural Environments
Reese, Kristin
Holmes, Alison
PEDIATRIC CLINICS OF NORTH AMERICA, 2025, 72 (01) : 37 - 52
[5] Advances in the Care of Infants With Prenatal Opioid Exposure and Neonatal Opioid Withdrawal Syndrome
Mascarenhas, Margarida
Wachman, Elisha M.
Chandra, Iyra
Xue, Rachel
Sarathy, Leela
Schiff, Davida M.
PEDIATRICS, 2024, 153 (02)
[6] Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors
Bakhireva, Ludmila N.
Sparks, Aydan
Herman, Michael
Hund, Lauren
Ashley, Malia
Salisbury, Amy
PEDIATRIC RESEARCH, 2022, 91 (04) : 867 - 873
[7] Resource utilization and convalescent care cost in neonatal opioid withdrawal syndrome
Ronan, K.
Driscoll, C. A. Hughes
Decker, E.
Gopalakrishnan, M.
El Metwally, D.
JOURNAL OF NEONATAL-PERINATAL MEDICINE, 2023, 16 (01) : 49 - 57
[8] Neonatal Opioid Withdrawal Syndrome An Update on Developmental Outcomes
Benninger, Kristen L.
McAllister, Jennifer M.
Merhar, Stephanie L.
CLINICS IN PERINATOLOGY, 2023, 50 (01) : 17 - 29
[9] Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches
McPhail, Brooks T.
Emoto, Chie
Butler, Dawn
Fukuda, Tsuyoshi
Akinbi, Henry
Vinks, Alexander A.
JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (07) : 857 - 870
[10] Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics
van Hoogdalem, Matthijs W.
McPhail, Brooks T.
Hahn, David
Wexelblatt, Scott L.
Akinbi, Henry T.
Vinks, Alexander A.
Mizuno, Tomoyuki
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (01) : 87 - 103

← 1 2 3 4 5 →